SYDNEY — One of the few randomized phase 3 trials ever conducted in mesothelioma has found that keyhole surgery did not improve survival when compared with the standard treatment of talc pleurodesis.
Johnson & Johnson is willing to pay almost $9 billion to settle thousands of lawsuits alleging that its talcum powder caused cancers, the company announced Apr. 4. The proposal is the latest chapter ...